Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Physiological Uptake in FDG PET Simulating Disease

Ahmad Sarji S., (2006) Physiological Uptake in FDG PET Simulating Disease. Biomedical Imaging and Intervention Journal, 2 (4).

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
650Kb

Official URL: http://www.biij.org/2006/4/e59/e59.pdf

Affiliations

University of Malaya, Faculty of Medicine, Dept. of Biomedical Imaging

Abstract

Many potential pitfalls and artefacts have been described in PET imaging that uses F-18 fluorodeoxyglucose (FDG). Normal uptake of FDG occurs in many sites of the body and may cause confusion in interpretation particularly in oncology imaging. Clinical correlation, awareness of the areas of normal uptake of FDG in the body and knowledge of variation in uptake as well as benign processes that are FDG avid are necessary to avoid potential pitfalls in image interpretation. In this context, optimum preparation of patients for their scans can be instituted in an attempt to reduce the problem. Many of the problems and pitfalls associated with areas of normal uptake of FDG can be solved by using PET CT imaging. PET CT imaging has the ability to correctly attribute FDG activity to a structurally normal organ on CT. However, the development of combined PET CT scanners also comes with its own specific problems related to the combined PET CT technique. These include misregistration artefacts due to respiration and the presence of high density substances which may lead to artefactual overestimation of activity if CT data are used for attenuation correction.

Item Type:Journal
Keywords:FDG PET, Physiological Uptake, Pitfalls, Artefacts
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:4547

1. Humes, S. Oncologic PET/CT: A primer for radiologists [Web Page]. Available at www.auntminnie.com.

2. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positronemission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26(4):308-14.

3. Cook GJ, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2- deoxyglucose and carbon-11 methionine. Eur J Nucl Med 1999; 26(10):1363-78.

4. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19(1):61-77; quiz 150-1.

5. Nguyen M, Varma V, Perez R, Schuster DM. CT with histopathologic correlation of FDG uptake in a patient with pulmonary granuloma and pleural plaque caused by remote talc pleurodesis. AJR Am J Roentgenol 2004; 182(1):92-4.

6. Murray JG, Erasmus JJ, Bahtiarian EA, Goodman PC. Talc pleurodesis simulating pleural metastases on 18Ffluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997; 168(2):359-60.

7. Cohen MS, Arslan N, Dehdashti F et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130(6):941-6.

8. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 2004; 34(2):122-33.

9. Brink I, Reinhardt MJ, Hoegerle S, Altehoefer C, Moser E, Nitzsche EU. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med 2001; 42(4):591-5.

10. Ferdinand B, Gupta P, Kramer EL. Spectrum of thymic uptake at 18F-FDG PET. Radiographics 2004; 24(6):1611-6.

11. Nuclear Medicine: PET Oncologic Imaging [Web Page]. Available at www.auntminnie.com.

Repository Staff Only: item control page